Purpose: To perform a risk mitigation review of intravitreal injections. Methods: A pan-European expert team conducted a healthcare failure modes and effects analysis (HFMEA) of intravitreal injection techniques. Possible failures at each stage were identified and potential causes and effects considered. A risk value (1-10) was assigned for each failure's severity, probability of occurrence and likelihood of going undetected, and a risk priority number (RPN) calculated. Results: This HFMEA revealed 91 intravitreal injection failure modes, of which 28, deemed to have an appreciable risk, were explored. Recommendations were proposed to reduce these risks, mostly relating to patient, staff, room and equipment preparation, injection procedure a...
Purpose: Intravitreal drug injection is typically performed with 30 gauge cannulas using liquid or g...
PURPOSE: To evaluate the incidence of presumed endophthalmitis (EO) after intravitreal injection (IV...
Purpose:Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (I...
Purpose: At the Kellogg Eye Center, we identified a series of injection-related patient safety event...
ABSTRACT: The purpose of this study is to show how a private eye care center in Turkey initiated Six...
The purpose of this study is to show how a private eye care center in Turkey initiated Six Sigma pri...
Purpose: To report the incidence of traumatic lens injuries as a complication of intravitreal inject...
Purpose. To report the occurrence of endophthalmitis and other complications after intravitreal inje...
Purpose: Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (...
The delivery of medications directly into the vitreous cavity through an injection or implant has be...
PURPOSE: To report on the occurrence of endophthalmitis after intravitreal injections (IVI) in t...
P>Background:To assess the techniques and materials used in intravitreal injections.Design:Descripti...
PURPOSE: To evaluate the real-life safety profile of intravitreal dexamethasone implant injection f...
Rajen Tailor, Rebecca Beasley, Yit Yang, Niro NarendranWolverhampton and Midland Counties Eye Infirm...
© 2015 Gazi Eye Foundation. All Rights Reserved.Purpose: To report the incidence of acute postoperat...
Purpose: Intravitreal drug injection is typically performed with 30 gauge cannulas using liquid or g...
PURPOSE: To evaluate the incidence of presumed endophthalmitis (EO) after intravitreal injection (IV...
Purpose:Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (I...
Purpose: At the Kellogg Eye Center, we identified a series of injection-related patient safety event...
ABSTRACT: The purpose of this study is to show how a private eye care center in Turkey initiated Six...
The purpose of this study is to show how a private eye care center in Turkey initiated Six Sigma pri...
Purpose: To report the incidence of traumatic lens injuries as a complication of intravitreal inject...
Purpose. To report the occurrence of endophthalmitis and other complications after intravitreal inje...
Purpose: Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (...
The delivery of medications directly into the vitreous cavity through an injection or implant has be...
PURPOSE: To report on the occurrence of endophthalmitis after intravitreal injections (IVI) in t...
P>Background:To assess the techniques and materials used in intravitreal injections.Design:Descripti...
PURPOSE: To evaluate the real-life safety profile of intravitreal dexamethasone implant injection f...
Rajen Tailor, Rebecca Beasley, Yit Yang, Niro NarendranWolverhampton and Midland Counties Eye Infirm...
© 2015 Gazi Eye Foundation. All Rights Reserved.Purpose: To report the incidence of acute postoperat...
Purpose: Intravitreal drug injection is typically performed with 30 gauge cannulas using liquid or g...
PURPOSE: To evaluate the incidence of presumed endophthalmitis (EO) after intravitreal injection (IV...
Purpose:Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (I...